(3R,4S)-3-[3-[3-chloro-5-(trifluoromethoxy)anilino]-2-oxopiperidin-1-yl]-1-ethylpiperidine-4-carboxylic acid
C20H25ClF3N3O4 — CID 153217778
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3R,4S)-3-[3-[3-chloro-5-(trifluoromethoxy)anilino]-2-oxopiperidin-1-yl]-1-ethylpiperidine-4-carboxylic acid
(3R,4S)-3-[3-[3-chloro-5-(trifluoromethoxy)anilino]-2-oxopiperidin-1-yl]-1-ethylpiperidine-4-carboxylic acid (PubChem CID 153217778) has the molecular formula C20H25ClF3N3O4 and a molecular weight of 463.88 g/mol. Its IUPAC name is (3R,4S)-3-[3-[3-chloro-5-(trifluoromethoxy)anilino]-2-oxopiperidin-1-yl]-1-ethylpiperidine-4-carboxylic acid.
Molecular Properties
| Compound Name | (3R,4S)-3-[3-[3-chloro-5-(trifluoromethoxy)anilino]-2-oxopiperidin-1-yl]-1-ethylpiperidine-4-carboxylic acid |
|---|---|
| PubChem CID | 153217778 |
| Molecular Formula | C20H25ClF3N3O4 |
| Molecular Weight | 463.88 g/mol |
| Exact Mass | 463.15 |
| IUPAC Name | (3R,4S)-3-[3-[3-chloro-5-(trifluoromethoxy)anilino]-2-oxopiperidin-1-yl]-1-ethylpiperidine-4-carboxylic acid |
| SMILES | CCN1CC[C@H](C(=O)O)[C@@H](N2CCCC(Nc3cc(Cl)cc(OC(F)(F)F)c3)C2=O)C1 |
| InChI | InChI=1S/C20H25ClF3N3O4/c1-2-26-7-5-15(19(29)30)17(11-26)27-6-3-4-16(18(27)28)25-13-8-12(21)9-14(10-13)31-20(22,23)24/h8-10,15-17,25H,2-7,11H2,1H3,(H,29,30)/t15-,16?,17-/m0/s1 |
| InChIKey | WNAXAIOEFYHNGC-QRFGZVGRSA-N |
| XLogP | 3.44 |
| TPSA | 82.11 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 463.88 |
| LogP ≤ 5 | 3.44 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153217778 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.